The Prevalence of Adverse Drug Reactions and Adverse Drug Events from Heart Failure Medications in Frail Older Adults: A Systematic Review
ConclusionThe potential harms from heart failure medications in frail older people are poorly studied and understood. Clinical trials and pharmacovigilance studies should include frailty as a covariate to inform medication optimisation for this vulnerable and growing population.RegistrationProspero registration number: CRD 42021253762.Graphical Abstract
Source: Drugs and Aging - Category: Geriatrics Source Type: research
More News: Cardiology | Clinical Trials | Diovan | Drugs & Pharmacology | Enalapril | Geriatrics | Heart | Heart Failure | Study | Tekturna